ClinicalTrials.gg
Enrolling by invitationNCT06388395Updated Jul 25, 2024

Clinical Performance of All-on-4 PEEK and Conventional Prostheses

An interventional study of Accuracy of full-arch surgical guides and Survival and complications of the prostheses in Failure, Prosthesis, Dental Prosthesis, Implant-Supported and Survival, Prosthesis, sponsored by University of Sharjah. Enrolling by invitation at 1 site in United Arab Emirates. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-25.

Sponsored by University of Sharjah · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The all-on-4 treatment approach for completely edentulous mandible is a proven concept. However, there are still issues regarding the use of metal substructure to support the prostheses such as allergy, metallic taste, and aesthetic. Therefore, other materials such as polyetheretherketone (PEEK) are being tested for its suitability and is showing good potential. However, available evidence is limited regarding its clinical performance. Thus, the aim of this study is to compare clinical performance of all-on-4 treatment concept utilizing PEEK versus conventional metal framework as substructure in fully edentulous mandible. Thirty suitable patients will receive either PEEK or conventional all-on-4 prostheses for fully edentulous mandible. The prostheses will be retained by four implants utilizing the all-on-4 principle. Clinical performance will be assessed during the follow up period of up 3 years concerning screw loosening, material chipping or fracture, wear or staining, prosthesis survival and success, implant survival and success.

Read the detailed description

The objectives of this randomized clinical trial are to 1) compare clinical performance of the two different treatment concepts during the follow up period of up to 3 years concerning prosthesis survival and success, 2) to assess the implants survival and success rates after 3 years, 3) to assess the accuracy of two surgical guides for full-arch implant surgery, 4) to assess the anticipated and actual pain following implant surgery, and 5) to assess patient satisfaction and quality of life will be assessed.

The study will be conducted according to the guidelines of the CONSORT statement for reporting randomized clinical. The study will be conducted at the College of Dental Medicine, University of Sharjah, United Arab Emirates.

Population and sample Study patients will be recruited from an existing pool of edentate adults referred for treatment to the College of Dental Medicine, University of Sharjah, United Arab Emirates. The patients will not be charged any treatment costs as part of this study. The target population will comprise patients requiring treatment for edentulous arches. Eligible patients for the implant phase of the study will be evaluated through a clinical assessment, panoramic radiograph, and cone-beam computed tomography (CBCT) exam. All study patients will be provided with a patient information sheet and provided written consent to take part in the study.

Conventional upper and lower denture constructions In the first phase of treatment, new maxillary and mandibular complete dentures with acceptable function and esthetics will be made and deliver to the patients. The conventional maxillary and mandibular complete denture constructions will follow the established methods which are primary impression with compound impression material, secondary impression with zinc oxide eugenol, jaw relation, try-in, issue and recall. The satisfactory mandibular complete denture will be converted into provisional all-on-4 mandibular prostheses immediately after implants placement.

Implant treatment planning The implant surgery planning will be performed using CBCT images of the anterior mandible obtained with a limited Field of View and standard protocols for minimizing radiation exposure. Implant placement planning and construction of surgical guides will be accomplished using available software and 3D printing machine. Implant placement will be fully guided surgery. The accuracy of two surgical guides will be assessed (milled and 3D-printed) by obtaining another CBCT after 3 months. The pre- and post-treatment scans will be superimposed and evaluated using Geomagic Control software.

Implant surgeries All implant surgeries will be performed by one surgeon. Surgeries will be carried out under local anesthesia. Four axial and tilted implants (All-on-4) will be placed in association with the treatment protocol. Four dental implants with a platform-switching design (Replace Conical Connection; Nobel Biocare, Zurich, Switzerland) will be placed with computer-guided technology (Nobel Guide; Nobel Biocare, Zurich, Switzerland) in the mandible at the lateral incisor and distal to first premolar sites. Primary stability of more than 35 Ncm will be achieved for all implants.

Pain Evaluation Anticipated pain will be recorded before surgery using visual analog scale (VAS) and actual pain levels will be recorded at day 1, 2 and 4 and at week 1, 2 and 3 after surgery using VAS.

Prostheses constructions Provisional prostheses Following implant placement, straight and 30-degree angled multiunit abutments will be torqued to the implants. Temporary abutments will be connected to the multiunit abutments, and the mandibular denture will be hollowed out to accommodate the temporary abutments. Rubber dam will be used to isolate the underlying soft tissue, and the temporary abutments will be connected to the denture with acrylic resin and picked up with the conversion prosthesis technique. The provisional prosthesis will be torqued to the multiunit abutments at 15 Ncm, and the screw access holes will be filled with Teflon tape and composite resin.

Definitive prostheses (conventional) Conventional hybrid prostheses combining metal frameworks as substructure, acrylic teeth and acrylic soft tissue will be constructed after three months of implants placement according to published protocols. Shimstock foil (GMH; Hanel Medizinal, Nu€rtingen, Germany) will be used for minor occlusal assessments during delivery of the prostheses. The prostheses will be torqued to the multi-unit abutments at 15Ncm, and the screw access holes will be filled with Teflon tape and composite resin (Z250, 3M ESPE, Minneapolis/St. Paul, MN). Oral hygiene instructions will be given to the patients. The follow up will be a week, three months, six months, a year, and 18 months or as needed by the patients. All prosthodontics procedures will be performed by the same prosthodontist.

Definitive prostheses (PEEK) Like conventional hybrid prostheses, the PEEK frameworks hybrid prostheses will also be constructed three months after implants' placement. The prostheses frameworks will be fabricated from modified PEEK (BioHPP; bredent GmbH \& Co KG). The definitive impression will be made with a custom tray (Fastray LC; Harry J. Bosworth Co), medium viscosity polyether impression material (Impregum Penta; 3M ESPE), and low shrinkage auto polymerizing acrylic resin (GC pattern resin; GC America Inc) to splint the impression copings for better accuracy. The definitive cast will be poured with Type IV dental stone (Prima-Rock; Whip Mix Corp), and an accuracy transfer index will be fabricated on this cast. This index will be transferred intraorally to verify implant position. The implant misfit will be accommodated by sectioning the index and reconnecting it using the same low-shrinkage resin. This corrected position will be transferred onto the definitive cast by removing the analog from the cast and re-attaching and repositioning it with the transfer index in place. Once the accuracy of the definitive casts has been verified, a facebow transfer and an interocclusal centric relation record will be made using a conventional occlusal wax rim. The casts will be mounted on the semi-adjustable articulator (Denar Mark II; Whip Mix Corp). The cast with the implant abutments in place will be scanned with a laboratory scanner (Dental Create; Smart Optics GmbH); the implant framework will be digitally designed using digital software (Exocad; Exocad America Inc); and a wax implant framework pattern will be fabricated using CAD-CAM technology (DMU 80P duoBLOCK; DMG MORI). The wax frameworks will be made to fit over the selected abutments, which will be incorporated into the framework by using a sculpting wax (Thowax; Yeti Dental) and then cast in 1 piece from modified PEEK, using the conventional lost wax technique, using a special investment (Brevest; bredent GmbH \& Co KG) and vacuum press device (2 press; bredent GmbH \& Co KG) designed for this material. The fit of the PEEK framework will be verified intraorally, as is the space for the acrylic teeth and pink PMMA. The prostheses will clinically be evaluated to ensure correct tooth position, midline, esthetics, and phonetics. The PEEK framework will then be used to fabricate hybrid prostheses like conventional one. The implant supported prostheses will be tightened to 30 Ncm according to the manufacturer's instructions. Specific oral hygiene instructions will be given to the patients. The follow up will be a week, three months, six months, a year, and 18 months or as needed by the patients. All prosthodontic procedures will be performed by the same prosthodontist.

02

Conditions studied

  • Failure, Prosthesis
  • Dental Prosthesis, Implant-Supported
  • Survival, Prosthesis
  • Complete Edentulism
  • Complication;Prostheses

Browse trials for

03

In context

Prosthesis Failure

119 studies on the registry are indexed under Prosthesis Failure; 35 are open to participants now.

This study's planned enrollment of 30 is below the median of 36 across 69 interventional studies indexed under Prosthesis Failure.

Browse Prosthesis Failure studies →

Lead sponsor

University of Sharjah is the lead sponsor of 42 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • no for implant surgery (including uncontrolled systemic diseases)
  • sufficient bone height in the inter-foraminal area for an implant length of at least 10 mm
  • ridge width of 5.5 mm for implant insertion of at least 3.5 mm in diameter,

Exclusion criteria

Exclusion Criteria:

  • individuals who disagreed with being randomly allocated to the treatment study groups, those with signs of untreated temporomandibular disorders or uncontrolled systemic or oral conditions requiring additional treatment, participants unable to understand and answer the questionnaires used in the study, and unable to attend the scheduled post-treatment appointments for longitudinal data collection.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Accuracy of full-arch surgical guides

    Two surgical guides (milled and 3D printed) will be used randomly to assess the accuracy of the guides following guided implant surgery.

    Procedure: Accuracy of full-arch surgical guides

  • Experimental
    Survival and complications of the prostheses

    The clinical performance of the two different treatment concepts during the follow up period of 3 years concerning screw loosening, veneering material chipping, wear or staining, prosthesis survival and success will be assessed.

    Procedure: Survival and complications of the prostheses

  • Experimental
    Survival and complications of the implants

    The implants survival and success rates will be evaluated after 1, 2 and 3 years of prostheses insertion.

    Procedure: Survival and complications of the implants

  • Experimental
    Conventional implant-supported prosthesis

    Full-arch implant-supported conventional (metal-resin) prosthesis will be constructed and assessed for up to 3 years

    Procedure: Conventional (metal-resin) implant-supported prosthesis

  • Experimental
    PEEK implant-supported prosthesis

    Full-arch implant-supported PEEK prosthesis will be constructed and assessed for up to 3 years

    Procedure: PEEK implant-supported prosthesis

Interventions

  • ProcedureAccuracy of full-arch surgical guides

    The accuracy of the surgical guides will be assessed by superimposing the pre and post-treatment CBCT scans.

  • ProcedureSurvival and complications of the prostheses

    Two different prostheses will be assessed (conventional and PEEK). All complications will be recorded for a period of 3 years

  • ProcedureSurvival and complications of the implants

    The effect of the two different prostheses on implants will be assessed in terms of survival and success rates.

  • ProcedureConventional (metal-resin) implant-supported prosthesis

    Full-mouth implant-supported conventional prosthesis will be constructed and evaluated for up to 3 years.

  • ProcedurePEEK implant-supported prosthesis

    Full-mouth implant-supported PEEK prosthesis will be constructed and evaluated for up to 3 years.

06

What researchers measure

Primary outcomes

  1. Accuracy of full-arch surgical guides

    Two types of surgical guides will be assessed for the accuracy. CBCT scans before and after surgery will be imported into 3D inspection software (Geomagic, 3D Systems Inc., Rock Hill, SC) for merging and evaluation of 3D deviations. Following software best-fit alignment, the 3D comparison will be used to evaluate the 3D deviations between the scans limited to the implants. Root man square (RMS) deviations will be recorded.

    Time frame: 6 months

  2. Survival rate of implants

    Implant survival will be assessed clinically and radiographically every year. The criteria for implant success according to Buser et al, were no radiolucent zone around the implant, confirmed individual implant stability, and no suppuration, pain or ongoing pathologic processes (Buser et al., 1997). All implants that failed to fulfill these criteria will be regarded as failures.

    Time frame: 3 years

  3. Success rates of the Prostheses

    Successful prosthesis must be free from any of the following technical complications: screw loosening, screw fracture, veneer material fracture or chipping, bulk fracture. Kaplan-meier analysis will be used.

    Time frame: 3 years

  4. Pain level

    Anticipated and actual pain will be assessed before and after surgery using the 10-cm visual analog scale (VAS) ranging from 0 "no pain" to 10 "worst pain ever." The scale has no other markings along the line. Patients will be asked to record their pain level before surgery and after surgery, 24 hours after surgery, at day 2, day 4 and at week 1, week 2, and week 3.

    Time frame: 1 months

Secondary outcomes

  1. Marginal bone loss

    Bone loss around implants will be measured radiographically every year for up to 3 years. All measurements will be done by one examiner, and radiographs will be analyzed using specially designed computer software (DicomWorks, Biomedical Engineering, the Netherlands) to perform linear measurements. Ideally, should be no bone loss, the higher the number after measurement the higher bone lost (resorbed) around implants.

    Time frame: 3 years

  2. Plaque index

    The presence of plaque will be recorded using a plaque indicator liquid (Mira-2 Ton Liquid; Hager \& Werken). The number of plaque sites will be analyzed according to modified plaque Index. Mild represents only 30% with plaque, moderate when up to 60% and severe when more than 60%.

    Time frame: 3 years

  3. Pocket depth

    Pocket depth around implants will be meaured at baseline and every year using dental probe with light force (0.25 N). Pocket depths around healthy implants should generally be less than 5 mm in depth. Pockets more than 5 mm are indicative of an inflammation.

    Time frame: 3 years

  4. Bleeding index

    Bleeding around implants will be assessed at baseline and every year using dental probe with light force (0.25 N) at six-points according to modified bleeding Index. Score 1 (up to 2 sites), score 2 (2-4 sites), score 3 (all sites).

    Time frame: 3 years

07

Study locations

1 site
08

References and documents

Publications

  • Malo P, de Araujo Nobre M, Rangert B. Short implants placed one-stage in maxillae and mandibles: a retrospective clinical study with 1 to 9 years of follow-up. Clin Implant Dent Relat Res. 2007 Mar;9(1):15-21. doi: 10.1111/j.1708-8208.2006.00027.x. PubMed 17362493 ↗
  • Patzelt SB, Bahat O, Reynolds MA, Strub JR. The all-on-four treatment concept: a systematic review. Clin Implant Dent Relat Res. 2014 Dec;16(6):836-55. doi: 10.1111/cid.12068. Epub 2013 Apr 5. PubMed 23560986 ↗
  • Sailer I, Philipp A, Zembic A, Pjetursson BE, Hammerle CH, Zwahlen M. A systematic review of the performance of ceramic and metal implant abutments supporting fixed implant reconstructions. Clin Oral Implants Res. 2009 Sep;20 Suppl 4:4-31. doi: 10.1111/j.1600-0501.2009.01787.x. PubMed 19663946 ↗
  • Fabbri G, Sorrentino R, Brennan M, Cerutti A. A novel approach to implant screw-retained restorations: adhesive combination between zirconia frameworks and monolithic lithium disilicate. Int J Esthet Dent. 2014 Winter;9(4):490-505. PubMed 25289384 ↗
  • Rubo JH, Capello Souza EA. Finite-element analysis of stress on dental implant prosthesis. Clin Implant Dent Relat Res. 2010 Jun 1;12(2):105-13. doi: 10.1111/j.1708-8208.2008.00142.x. Epub 2009 Feb 13. PubMed 19220846 ↗
  • Ciftci Y, Canay S. The effect of veneering materials on stress distribution in implant-supported fixed prosthetic restorations. Int J Oral Maxillofac Implants. 2000 Jul-Aug;15(4):571-82. PubMed 10960992 ↗
  • Davis DM, Rimrott R, Zarb GA. Studies on frameworks for osseointegrated prostheses: Part 2. The effect of adding acrylic resin or porcelain to form the occlusal superstructure. Int J Oral Maxillofac Implants. 1988 Winter;3(4):275-80. No abstract available. PubMed 3075967 ↗
  • Gracis SE, Nicholls JI, Chalupnik JD, Yuodelis RA. Shock-absorbing behavior of five restorative materials used on implants. Int J Prosthodont. 1991 May-Jun;4(3):282-91. PubMed 1810320 ↗
  • Stijacic T, Chung KH, Flinn BD, Raigrodski AJ. Effect of Tooth-Colored Restorative Materials on Reliability of Heat-Pressed Lithium Disilicate. J Prosthodont. 2015 Aug;24(6):475-83. doi: 10.1111/jopr.12243. Epub 2014 Dec 17. PubMed 25522165 ↗

Individual participant data

Plan to share: No — Individuals data will not be shared, data required normally for publication will be shared upon reasonable request.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Aug 2024; primary completion for Jun 2027, 34 months later.

Of 48 non-industry interventional studies with no phase under Prosthesis Failure, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 51. This study's planned 34 months is above that.

Counting every sponsor, half of 50 studies reached it within 18 months; a quarter within 9 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 22, 2024
First posted
Apr 29, 2024
StartEst.
Aug 1, 2024
Primary completionEst.
Jun 30, 2027
CompletionEst.
Aug 30, 2027
Last update
Jul 25, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 25, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06388395
Lead sponsor
University of Sharjah
Responsible party
Ahmed Aziz (Assistant Professor, University of Sharjah) — Principal investigator
First posted
Apr 29, 2024
Start date
Aug 1, 2024 (estimated)
Primary completion
Jun 30, 2027 (estimated)
Completion
Aug 30, 2027 (estimated)
Last update
Jul 25, 2024

Study contacts

Ahmed Aziz, PhD
principal investigator · University of Sharjah

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion